Philips, a global leader in healthcare technology, has unveiled the Transcend Plus, the advanced version of its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems. This innovative system offers significant enhancements in image quality and incorporates artificial intelligence (AI) for improved diagnostic capabilities in cardiology. With FDA-cleared 2D and 3D image improvements, Transcend Plus enhances sharpness, contrast, and detail, increasing diagnostic confidence even in complex cases. The system features 26 AI-enabled clinical applications, the most in the industry, including 2D Auto EF and 2D Auto EF Advanced, which optimize clinical workflows and accuracy. According to Dr. Akhil Narang, AI serves as a powerful tool alongside human expertise, streamlining processes and providing reproducible measurements in cardiac evaluations. Philips ultrasound systems facilitate 1.33 billion diagnostic procedures annually, benefiting 654 million patients worldwide, thereby addressing challenges like rising patient volumes and staffing shortages in cardiology.
